Concepedia

Concept

translational tissue engineering

Parents

Children

3K

Publications

195.8K

Citations

12.5K

Authors

2.5K

Institutions

Translational Scaffolded Tissue Engineering

1999 - 2006

During 1999–2006, translational tissue engineering emphasized scaffold-driven maturation and autologous cell sources as the core engine for clinically relevant constructs. Bioreactor- and mechanically conditioned culture environments emerged as central determinants of tissue maturation, guiding extracellular matrix composition and mechanical properties in cartilage and bone constructs. Scaffold architecture and biomaterial chemistry defined the enabling platform, directing cell–matrix interactions, mineralization, and tissue organization across bone and cartilage models.

Bioreactor- and mechanically conditioned culture environments emerge as central determinants of tissue maturation, guiding extracellular matrix composition and mechanical properties in engineered constructs across cartilage and bone platforms [2], [10], [1], [18].

Scaffold architecture and biomaterial chemistry serve as primary enabling platforms for tissue formation, with material choice and structure directing cell–matrix interactions, mineralization, and tissue organization in bone and cartilage constructs [9], [16], [12], [17], [11].

Diverse cell sources and lineage potential—especially adipose-derived multipotent cells and mesenchymal stem cell platforms—provide substrates for autologous tissue engineering, supporting chondrogenic and osteogenic differentiation within scaffold environments [5], [3], [4], [16], [12].

Cartilage engineering strategies combine in vitro chondrogenesis with in vivo culture or carrier systems and modeling of matrix deposition (GAG and type II collagen) to predict maturation and guide transplantation [6], [13], [17], [4].

Translational Cartilage Engineering

2007 - 2013

Scaffold-Guided Translational Biofabrication

2014 - 2016

Translational Multiscale Biofabrication

2017 - 2023